McKesson Cash on Hand 2010-2022 | MCK

McKesson cash on hand from 2010 to 2022. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • McKesson cash on hand for the quarter ending June 30, 2022 was $2.233B, a 7.84% decline year-over-year.
  • McKesson cash on hand for 2022 was $3.532B, a 43.74% decline from 2021.
  • McKesson cash on hand for 2021 was $6.278B, a 56.36% increase from 2020.
  • McKesson cash on hand for 2020 was $4.015B, a 34.69% increase from 2019.
McKesson Annual Cash on Hand
(Millions of US $)
2022 $3,532
2021 $6,278
2020 $4,015
2019 $2,981
2018 $2,672
2017 $2,783
2016 $4,048
2015 $5,341
2014 $4,193
2013 $2,456
2012 $3,149
2011 $3,612
2010 $3,731
2009 $2,109
McKesson Quarterly Cash on Hand
(Millions of US $)
2022-06-30 $2,233
2022-03-31 $3,532
2021-12-31 $2,754
2021-09-30 $2,151
2021-06-30 $2,423
2021-03-31 $6,278
2020-12-31 $3,577
2020-09-30 $3,091
2020-06-30 $2,613
2020-03-31 $4,015
2019-12-31 $2,065
2019-09-30 $1,356
2019-06-30 $1,947
2019-03-31 $2,981
2018-12-31 $1,849
2018-09-30 $2,118
2018-06-30 $2,199
2018-03-31 $2,672
2017-12-31 $2,619
2017-09-30 $2,563
2017-06-30 $2,339
2017-03-31 $2,783
2016-12-31 $2,434
2016-09-30 $5,464
2016-06-30 $4,659
2016-03-31 $4,048
2015-12-31 $3,406
2015-09-30 $5,359
2015-06-30 $5,635
2015-03-31 $5,341
2014-12-31 $4,587
2014-09-30 $3,804
2014-06-30 $4,105
2014-03-31 $4,193
2013-12-31 $2,431
2013-09-30 $2,960
2013-06-30 $2,905
2013-03-31 $2,456
2012-12-31 $2,726
2012-09-30 $2,831
2012-06-30 $2,013
2012-03-31 $3,149
2011-12-31 $4,191
2011-09-30 $3,943
2011-06-30 $3,116
2011-03-31 $3,612
2010-12-31 $3,213
2010-09-30 $3,050
2010-06-30 $3,265
2010-03-31 $3,731
2009-12-31 $3,428
2009-09-30 $3,215
2009-06-30 $2,644
2009-03-31 $2,109
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $50.991B $263.966B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $72.810B 21.15
AmerisourceBergen (ABC) United States $30.314B 13.39
West Pharmaceutical Services (WST) United States $24.398B 37.15
Laboratory Of America Holdings (LH) United States $23.439B 10.25
Cardinal Health (CAH) United States $16.828B 12.92
Cooper (COO) United States $16.065B 24.73
CONMED (CNMD) United States $2.967B 29.25
Invacare (IVC) United States $0.033B 0.00